Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,631 public trials 442 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Completed

A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

NCT03783442

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • Smilow Cancer Hospital At Yale New Haven, Connecticut, United States
  • Renovatio Clinical The Woodlands, Texas, United States
  • Coffs Harbour Base Hospital Coffs Harbour, New South Wales, Australia
  • St Vincents Hospital Melbourne Fitzroy, Victoria, Australia
View all 124 locations
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

NCT04242199

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Upmc Cancercenter Pittsburgh, Pennsylvania, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View all 21 locations
View Trial Details
Completed

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

NCT04580485

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +59 more
Locations
  • Cedars-Sinai Medical Center West Hollywood, California, United States
  • University of Maryland-Greenebaum Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 27 locations
View Trial Details
Completed

A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)

NCT04489888

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 0265) New Haven, Connecticut, United States
  • Helen F. Graham Cancer Center & Research Institute ( Site 0214) Newark, Delaware, United States
  • Baptist MD Anderson Cancer Center ( Site 0215) Jacksonville, Florida, United States
  • Orlando Health, Inc. ( Site 0216) Orlando, Florida, United States
View all 35 locations
View Trial Details
Completed

A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands

NCT01351103

Conditions
BRAF Mutant Colorectal Cancer, Breast Diseases, Breast Neoplasms, +35 more
Locations
  • UCLA School of Medicine Los Angeles, California, United States
  • Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Baltimore, Maryland, United States
  • Dana Farber Cancer Institute SC-7 Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Onc Dept. Ann Arbor, Michigan, United States
View all 20 locations
View Trial Details

Related conditions